Actively Recruiting
A Global Record of Patients With Anal Squamous Cell Carcinoma With and Without HIV Infection
Led by Latin American Cooperative Oncology Group · Updated on 2025-03-07
300
Participants Needed
1
Research Sites
97 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Due to the scarcity of data on prognostic and predictive influence on CCA, epidemiological studies evaluating these factors need to be developed in patients with CCA. Therefore, the investigators want to evaluate the profile of patients in the real world and from various parts of the world, describing prognostic factors such as CD4 dosage, time of HIV infection, evaluation of viral load, diagnosis of AIDS, geographic region of diagnosis and treatment, clinical staging, medications concomitant with QRT (risk of drug interactions), comorbidities (possible impact on dose-intensity), use of HAART, time of use of HAART, radiotherapy modality (conventional 3D vs Modulated Beam Intensity \[IMRT\], response to Nigro vs CTII regimens, as well as comparing clinical outcomes with patients without HIV infection.
CONDITIONS
Official Title
A Global Record of Patients With Anal Squamous Cell Carcinoma With and Without HIV Infection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 18 years of age or older
- Confirmed histological diagnosis of anal canal squamous cell carcinoma, including basaloid subtype
- Have undergone serological testing for HIV infection
- Any clinical stage of disease
You will not qualify if you...
- Missing data on treatments and clinical outcomes
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
A.C. Camargo Cancer Center
São Paulo, Brazil, 01509-001
Actively Recruiting
Research Team
V
Viviane Horn de Melo
CONTACT
L
Laura Voelcker
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here